PDS Biotechnology Corp's latest layoff filing, on August 25, 2026, states a cut of about 36% of its workforce. As of November 6, 2026, it has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, August 25, 2026).
Who owns PDS Biotechnology Corp?
12 companies announced layoffs this week.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| Artiva Biotherapeutics, Inc. | announced layoffs | |
| Eos Energy Enterprises, Inc. | announced layoffs | |
| SOUNDHOUND AI, INC. | announced layoffs | |
| Portillo's Inc. | announced layoffs | |
| Acumen Pharmaceuticals, Inc. | announced layoffs of about 52 employees |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of PDS Biotechnology Corp.
Free to see. No signup.
PDS Biotechnology Corp reported 1 exit or restructuring plan on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did PDS Biotechnology have layoffs in 2026? What its filings say
PDS Biotechnology Corp (CIK 1472091) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2026-08-25
Share of workforce
The reduction in force is expected to affect approximately 36% of the Company's workforce and is expected to be substantially completed during the third quarter of 2026.
Expected charges
As a result of the reduction in force, the Company estimates that it will record a one-time charge in the third quarter of 2026 related to employee separation benefits, including severance and related benefits, of approximately $842,000, all of which is anticipated to result in cash expenditures to be recognized in the third quarter of 2026.
Also on the record for PDS Biotechnology Corp
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 20, 2026 | Leadership change: Deborah A. Ramsdell appointed, Director | — | Leadership changes | Source |
| September 21, 2026 | Stake report, Schedule 13D, by Nant Capital, LLC | 19.9% of the class | 5%+ stakes | Source |
| September 14, 2026 | Leadership change: James Banaag appointed, Director | — | Leadership changes | Source |
| August 25, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| August 19, 2026 | Leadership change: Janetta Trochimiuk appointed, President and Chief Executive Officer | — | Leadership changes | Source |
| August 14, 2025 | Stake report, Schedule 13G/A, by Armistice Capital, LLC | 4.99% of the class | 5%+ stakes | Source |
Keep reading
More on PDS Biotechnology Corp and the records around it.
PDS Biotechnology Corp elsewhere on the record
- 5%+ stake filings Sep 2026
- Leadership changes Sep 2026
- Who owns it
Companies that share a holder
- Armistice Capital, LLC also filed stake reports on 120 other companies: Autolus Therapeutics plc (Aug 2026), Bicycle Therapeutics plc (Aug 2026), BioXcel Therapeutics, Inc. (Aug 2026)
Watch PDS Biotechnology Corp
Get an email when PDS Biotechnology Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with PDS Biotechnology Corp?
Want the whole picture on PDS Biotechnology Corp?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on PDS Biotechnology Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on PDS Biotechnology Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Tools for this story
Each opens in a new tab, filled in for PDS Biotechnology Corp. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Cite this page
https://mentionfox.com/layoffs/pds-biotechnology